PRODUCT DETAIL

Sacubitril/Valsartan STADA 97 mg/103 mg

Code

2062F

MA number

41/0421/25-S

Product Form:

tbl flm 20x97 mg/103 mg (blis.OPA/Al/PVC/Al)

MA Status:

R - Valid Marketing Authorisation

Type of procedure:

Decentralised

MAH, country:

STADA Arzneimittel AG, Germany

Therapeutic Class:

41 - CARDIACA

ATC:

C	CARDIOVASCULAR SYSTEM
C09	AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
C09D	ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS
C09DX	Angiotensin II receptor blockers (ARBs), other combinations
C09DX04	Valsartan and sacubitril

Shelf life:

Container:

blister OPA/Al/PVC/Al

Route of admin.:

Oral use

Prescription Status:	Medicinal product subject to medical prescription.
Legal basis:	Article 10(1) generic application
MA issued:	23.12.2025
Validity:	23.12.2030
Pediatric warnings:	Yes
PIL:	PIL_Sacubitril Valsartan STADA 24mg26mg, 49mg51mg, 97mg103mg_12_2025.pdf
SPC:	SPC_Sacubitril Valsartan STADA 24mg26mg, 49mg51mg, 97mg103mg_12_2025.pdf
Safety feature	Yes
Data update:	23.12.2025